Tiny Leg-Artery device put to the test: how much drug reaches the blood?

NCT ID NCT05208905

Ongoing Knowledge-focused Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 27 times

Summary

This study looks at how a drug-coated device (Esprit BTK) releases medication into the blood after being placed in leg arteries below the knee. About 7 people with severe leg artery disease (critical limb ischemia) will have their blood tested at many time points over 60 days. The goal is simply to measure drug levels, not to treat the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL LIMB ISCHEMIA (CLI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ascension St. John Jane Phillips

Bartlesville, Oklahoma, 74006, United States
Charlton Memorial Hospital

South Dartmouth, Massachusetts, 02747, United States
First Coast Cardiovascular Institute

Jacksonville, Florida, 32256, United States
National Taiwan University Hospital

Taipei, Taiwan
Sir Charles Gairdner Hospital

Nedlands, WAUS, Australia

Conditions

Explore the condition pages connected to this study.

CRITICAL LIMB ISCHEMIA (CLI)